Connect with us

Health

19 new coronavirus cases reported in Saskatchewan, hits single-day testing record – Global News

Published

 on


Winnipeg police say a woman has died and several other people have been injured in a collision involving a vehicle that was fleeing police.

The crash happened at about 1:30 p.m. Saturday in the area of Salter Street and Boyd Avenue, police said in a statement.

According to police, officers tried to pull over a vehicle for a traffic stop but the driver “took off at a high rate of speed.”

Read more:
Vehicle-pedestrian collision on Portage Ave. leaves one person in critical condition

Seconds later, the vehicle hit another car in the nearby intersection of Andrews Street and Boyd Avenue.

Four people in the vehicle that was struck — including an infant and a child — were sent to hospital.  A woman who was in that vehicle has died from her injuries, police said.

Story continues below advertisement

Two people from the vehicle that had fled police were also transported to hospital.






0:24
No injuries reported after school bus crashes into hydro pole in downtown Winnipeg


No injuries reported after school bus crashes into hydro pole in downtown Winnipeg

The Independent Investigation Unit of Manitoba, which investigates serious incidents involving police, has been called to investigate.

In a press conference Saturday evening, Winnipeg Police Const. Rob Carver said that almost everyone in the collision was in either serious or critical condition.

“Incredibly tragic, we’ve got an infant in the vehicle, a child in the vehicle, a woman who was killed in this crash, tragic all around,” said Carver, who also stressed that the incident was not a result of a police pursuit.

A photo of the crash scene near Salter Street and Boyd Avenue.


A photo of the crash scene near Salter Street and Boyd Avenue.


Global News

“We pulled up, we attempted to have this vehicle spoken to, and the vehicle fled. We did not pursue it.”

Story continues below advertisement

For the two people in the fleeing vehicle, Carver said he does not have an idea on their injuries, but that they will at some point be taken into custody “when their medical condition allows for that.”

“In the space of less than half a minute … what started out as a routine incident ended up with multiple people in the hospital and a woman killed, and these people were not connected at all.”

— With files from Global News’ David Lao

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Hinshaw cuts runny nose, sore throat from list of COVID-19 symptoms forcing kids to isolate: Groundwork – Gananoque Reporter

Published

 on


Parents running out of paid leave to care for a child with a simple runny nose or sore throat caught a break Thursday when Dr. Deena Hinshaw struck those from the list of core COVID-19 symptoms.

Mirroring updated regulations in B.C., Quebec and Ontario, children in Alberta will no longer have to self-isolate for 10 days or get tested for the virus if they have only a sore throat or runny nose, two symptoms that are more likely to indicate a common childhood cold.

Taking effect Monday, the new requirement sends these children home for 24 hours instead, monitored in case symptoms get worse.

“Runny nose is a very, very common symptom, as is a sore throat, and it’s not very specific for COVID,” Alberta’s chief medical officer of health said in an interview before Thursday’s announcement.

Alberta residents will be coping with COVID-19 restrictions for months, Hinshaw said. This change is part of trying to make that burden as light as possible and gain maximum compliance.

“Measures that are in place that make peoples’ lives more difficult but don’t actually help that much to prevent COVID, we need to lift those when we have the evidence to do so,” she said.

There is still a mandatory 10-day isolation or testing requirement for children with a cough, fever, loss of taste or smell and/or shortness of breath.

Runny nose and sore throat are included in a longer list of secondary symptoms. If a child has one symptom from that list on the Alberta Health website they must stay home for 24 hours to see if the symptom worsens or more symptoms develop. If nothing gets worse, a child may return to school and other children’s activities, even if the symptom hasn’t resolved.

For students with two or more secondary symptoms, testing is still recommended. A child must stay home until symptoms go away or they test negative. The relaxed rules do not apply to adults yet.

Existing rules cause hardship

Many parents had been struggling with the isolation requirements, particularly when schools sent students home for a simple runny nose.

In the Edmonton Journal’s Groundwork engagement project, parents reported having to call in more vulnerable grandparents to help when kids come down with a cold. They’re being forced to call in sick themselves, which creates additional staffing challenges for schools, hospitals and other workplaces.

Isolating a child is really tough when parents have to keep leaving the house to get groceries or bring other children to school, said Laura Shyko in an interview. Her three elementary-school aged children came down with runny noses, testing negative for COVID-19, one after the other.

She didn’t have the heart to drag the last one, a five-year-old, kicking and screaming to get the nasal swab. “It was all so clear she just had a cold,” she said.

By now, parents are running out of paid leave themselves, said Joanna Coleman, who has had to leave work four separate times so far, with three children off school 13 days, for a variety of headaches and colds that tested negative for COVID-19.

At one point, the school sent her daughter home simply because her nose ran for 15 minutes after coming in from the cold. A single mom, she is now out of paid vacation and sick days. “I do understand the need for this,” she said. But anything that can safely streamline the process is appreciated. “We’re not going to be back to normal for a very long time.”

Data driving the change

Hinshaw said Alberta Health feels confident about making this change based on three different data sets — data showing a similar change did not significantly increase transmission in Ontario schools when it was made Oct. 1, symptom descriptions collected since the start of the pandemic after children test positive, and new data from Alberta on the children with a runny nose or sore throat who test negative for COVID-19.

On that last data set, technical challenges meant Alberta Health Services only recently started asking for a full list of symptoms from each person requesting a COVID-19 test online, Hinshaw said.

But in the last week, for example, 3,300 children under 18 said they had a runny nose when they applied for a test. Of those, 600 children had no other symptom. Two of those children then tested positive, and only one of them had no known connection to a positive COVID-19 case.

Under the new rules, only the child with just a runny nose and a close contact must stay home and get tested. The rest of the 600 could simply monitor for symptoms, then head back to school after 24 hours if symptoms didn’t worsen.

Alberta Health is still analyzing this type of data for adults and asked its science advisory panel to help. The current change does not apply to adults because they can have different symptoms, are at a higher risk of getting seriously ill from the disease, and are more likely to pass it on to others.

The risk is not zero

But it’s a difficult subject. The risk is not zero and Alberta has had record numbers of new daily COVID-19 cases lately. Of that group of 600 children with only a runny nose, one child still tested positive and that child would be at school, potentially infectious, under these new rules.

Through the Groundwork surveys and virtual office hours, the Edmonton Journal also heard from parents with children in school who were already anxious about peers not following the daily wellness check recommendations.

Many parents with children studying online say this is because they don’t trust that the in-school environment is safe enough. Some of them have medically-fragile family members to protect, and some wish they could let their children study safely at home but their jobs, children’s needs or the family situation makes that impossible.

“I completely understand that concern,” Hinshaw said, adding that this change is about balance and trying to gain compliance, knowing there will always be some risk at school because of asymptomatic transmission. “We’re not throwing caution to the wind, but saying: How can we make sure people can live with this for several months to come?”

estolte@postmedia.com

twitter.com/estolte

This article is part of Groundwork, an Edmonton Journal engagement initiative. Read more at edmontonjournal.com/groundwork.

Related

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Province reducing number of possible COVID-19 symptoms barring students from class – Calgary Herald

Published

 on


Article content continued

“We’re shifting toward a more targeted (symptoms) list . . . we must strike a difficult but necessary balance in responding to COVID-19 and also limit the harms our restrictions might cause,” said Hinshaw, adding the move aligns with policy in B.C., Ontario and Quebec.

But those with symptoms of loss of taste, fever, shortness of breath must still quarantine for 10 days or test negative before returning to class, she said.

The moves come as the number of CBE students and staff that have had to isolate since the start of the school year hit 5,500 and 500 respectively.

On Thursday, Hinshaw said there are 730 active cases linked to Alberta schools with active alerts or outbreaks at 249 schools, or 10 per cent of the province’s total.

There have been 87 in-school transmissions, said Hinshaw.

That announcement came as 477 new cases were reported provincewide on Wednesday, along with five more deaths from the virus, bringing the total number to 318, one of them a man in his 40s in the South zone.

Three of the deaths were in the Calgary zone involving patients in their 80s and 90s, with two of them in long-term care.

An outbreak at the Calgary Correctional Centre continues to worsen, with the number of infected inmates rising from 70 to 100 in the past day, while 18 staff members have tested positive.

The Opposition NDP said the province’s decision to relax the school symptoms list is a step backwards in protecting students and staff amid a series of outbreaks they blamed largely on provincial policy.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Moderna, BioNtech surge as COVID-19 vaccine development progresses amid virus spike | Markets – Business Insider

Published

 on


A photo illustration show a syringe. Argentina was selected to test a vaccine against COVID-19, it is estimated that the clinical phases will begin in August.

  • Moderna and BioNtech surged in Thursday trades amid updates on the development of a COVID-19 vaccine.
  • Investor focus on a potential vaccine is heightened as daily COVID-19 cases spike across the US and in Europe.
  • Moderna said it’s “actively preparing for the launch” of its COVID-19 vaccine, while a report from the Wall Street Journal said Germany could begin vaccinations this year with a BioNtech vaccine.
  • Visit the Business Insider homepage for more stories.

Moderna and BioNtech surged in Thursday trades as investor focus on a successful COVID-19 vaccine remained heightened amid a surge in daily virus cases.

Moderna traded higher by as much as 13%, while BioNtech jumped as much as 11%.

In its third quarter earnings report, Moderna said it’s “actively preparing for the launch” of its COVID-19 vaccine.

Moderna’s phase III trial of the vaccine candidate is fully enrolled with 30,000 patients.

To date, Moderna has received more than $1 billion in deposits from governments around the world who are eager to distribute a successful COVID-19 vaccine.

The most recent deal struck by Moderna was with Takeda of Japan, announced earlier today. Moderna will supply Takeda with 50 million doses of its COVID-19 vaccine in the first half of 2021 pending approval in Japan.

Depending on the results of a clinical trial, BioNtech’s COVID-19 vaccine could be rapidly distributed across Germany by the end of this year, The Wall Street Journal reported on Thursday.

Read more: BANK OF AMERICA: Buy these 6 food stocks best-positioned for stay-at-home Halloween celebrations as towns curb trick-or-treating

According to people familiar with the strategy, a plan is in place for doses of the BioNtech vaccine to be shipped to more than 60 regional vaccine centers in Germany within hours of approval.

Initial recipients of a successful COVID vaccine in Germany would include health-care workers, the elderly, and clinically vulnerable people, among others. 

BioNtech has partnered with Pfizer on the development of a COVID-19 vaccine and it hopes to submit its vaccine for authorization in November. 

BioNtech and Pfizer have already produced millions of doses of its vaccine so it can deliver on pre-purchasing contracts, according to The Wall Street Journal.

A vaccine couldn’t come soon enough. The US has experienced record daily virus cases this past weekend, and new lockdown measures have hit Germany and France as they attempt to contain a resurgence of the virus. 

Read More: Here’s the 6 killer pieces of advice for trading European stocks after the US election, from investment giants UBS and Barclays

Let’s block ads! (Why?)



Source link

Continue Reading

Trending